Expansion of the OTC pharmaceuticals and healthcare businesses through the acquisition of YOMEISHU SEIZO CO.,LTD. as a subsidiary

An M&A theme focused on making YOMEISHU SEIZO CO.,LTD. a wholly owned subsidiary and expanding the OTC pharmaceuticals, healthcare, and preventive health and wellness businesses by combining the company’s expertise in health maintenance and its brand with strengths in prescription Kampo formulations.